Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and Cytarabine (CNSLymphoma)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2007 by Assistance Publique - Hôpitaux de Paris.
Recruitment status was  Recruiting
French Innovative Leukemia Organisation
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris Identifier:
First received: July 18, 2007
Last updated: July 27, 2012
Last verified: July 2007